Background: Early during the course of the ongoing COVID-19 pandemic, reports suggested
alarmingly high incidences for thromboembolic events in critically ill patients with COVID-19 …

Nearly two years ago, the SARS-CoV-2 outbreak began, and our lives have changed
significantly since then. The increasing the number of submissions and articles to the …

Background: Emerging evidence shows that coronavirus disease 2019 (COVID-19) is
commonly complicated by coagulopathy, and venous thromboembolism (VTE) is considered …

Introduction COVID-19 associated VTE is a new disease entity with high morbidity and
mortality. The aim of this paper is to review contemporary emerging literature on the …

Patients with coronavirus disease 2019 (COVID-19) have elevated D-dimer levels. Early
reports describe high venous thromboembolism (VTE) and disseminated intravascular …

The course of COVID-19 is highly dependent on the associated cardiometabolic
comorbidities of the patient, which worsen the prognosis of coronavirus infection, mainly due …

Background We aimed to identify the prevalence and predictors of venous
thromboembolism (VTE) or mortality in hospitalized coronavirus disease 2019 (COVID-19) …

In October 2019, a viral infectious disease appeared in the city of Wuhan in China. A new
betacoronavirus, SARS-CoV-2, has been recognized as the responsible pathogen in this …

Background A significant proportion of patients with coronavirus disease 19 (COVID-19)
suffer from excessive coagulation activation and coagulopathy which is associated with an …

Abstract Coronavirus disease 2019 (COVID-19) is, at present, one of the most relevant
global health problems. In the literature hepatic alterations have been described in COVID …